New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - bimatoprost 0.3 mg/ml;  ;   - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml     excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide - monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - cefazolin sodium 1.048 g equivalent to cephazolin 1 g;   - powder for injection - 1 g - active: cefazolin sodium 1.048 g equivalent to cephazolin 1 g  

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - cefazolin sodium 2.096 g equivalent to cefazolin 2 g;   - powder for injection - 2 g - active: cefazolin sodium 2.096 g equivalent to cefazolin 2 g  

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - cefazolin sodium 524mg equivalent to cephazolin 500 mg;   - powder for injection - 500 mg - active: cefazolin sodium 524mg equivalent to cephazolin 500 mg  

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - amoxicillin sodium 1.06 g equivalent to amoxicillin 1 g;  ; potassium clavulanate 238.3mg equivalent to clavulanate 200 mg;  ;  ;   - powder for injection - 1.2 g - active: amoxicillin sodium 1.06 g equivalent to amoxicillin 1 g   potassium clavulanate 238.3mg equivalent to clavulanate 200 mg       - amoxiclav multichem is indicated for the short term treatment of common bacterial infections such as: -upper respiratory tract infections (including ent): e.g. tonsillitis, sinusitis, otitis media -lower respiratory tract infections: e.g. acute exacerbations of chronic bronchitis, lobar and broncho-pneumonia -genito-urinary tract infections: e.g. cystitis, urethritis, pyelonephritis, female genital infections -skin and soft tissue infections -bone and joint infections: e.g. osteomyelitis -other infections: e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, septicaemia, peritonitis, post-surgical infections amoxiclav multichem is indicated for prophylaxis against infection which may be associated with major surgical procedures such as gastro-intestinal, pelvic, head and neck, cardiac, renal, joint replacement and biliary tract surgery.

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - amoxicillin sodium 530mg equivalent to amoxicillin 500 mg;  ; potassium clavulanate 119.15mg equivalent to clavulanate 100 mg;  ;  ;   - powder for injection - 600 mg - active: amoxicillin sodium 530mg equivalent to amoxicillin 500 mg   potassium clavulanate 119.15mg equivalent to clavulanate 100 mg       - amoxiclav multichem is indicated for the short term treatment of common bacterial infections such as: -upper respiratory tract infections (including ent): e.g. tonsillitis, sinusitis, otitis media -lower respiratory tract infections: e.g. acute exacerbations of chronic bronchitis, lobar and broncho-pneumonia -genito-urinary tract infections: e.g. cystitis, urethritis, pyelonephritis, female genital infections -skin and soft tissue infections -bone and joint infections: e.g. osteomyelitis -other infections: e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, septicaemia, peritonitis, post-surgical infections amoxiclav multichem is indicated for prophylaxis against infection which may be associated with major surgical procedures such as gastro-intestinal, pelvic, head and neck, cardiac, renal, joint replacement and biliary tract surgery.

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - clopidogrel besilate 112.1mg equivalent to clopidogrel 75 mg;  ;   - film coated tablet - 75 mg - active: clopidogrel besilate 112.1mg equivalent to clopidogrel 75 mg     excipient: citric acid monohydrate crospovidone hyprolose macrogol 6000 mannitol microcrystalline cellulose opadry pink 32k14834 purified talc stearic acid - prevention of vascular ischaemia associated with atherothrombotic events (mi, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - mometasone furoate 1.02 mg/g - topical cream - 0.1% w/w - active: mometasone furoate 1.02 mg/g excipient: cetomacrogol 1000 cetostearyl alcohol dimeticone disodium edetate dihydrate hexylene glycol imidurea light liquid paraffin methyl hydroxybenzoate propyl hydroxybenzoate purified water - for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as psoriasis and atopic dermatitis.

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - mometasone furoate 1 mg/g (manufacturing formula includes includes 2 % overage (1.02 mg/g)); mometasone furoate 1 mg/g (manufacturing formula includes includes 2 % overage (1.02 mg/g)) - topical ointment - 0.1% w/w - active: mometasone furoate 1 mg/g (manufacturing formula includes includes 2 % overage (1.02 mg/g)) excipient: hexylene glycol macrogol stearate 1500 polysorbate 80 white beeswax white soft paraffin active: mometasone furoate 1 mg/g (manufacturing formula includes includes 2 % overage (1.02 mg/g)) excipient: hexylene glycol macrogol stearate 1500 polysorbate 80 white beeswax white soft paraffin - for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as psoriasis and atopic dermatitis.

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - thiamine hydrochloride 50mg (+5% manufacturing overage);  ;  ;   - tablet - 50 mg - active: thiamine hydrochloride 50mg (+5% manufacturing overage)       excipient: lactose monohydrate magnesium stearate microcrystalline cellulose